Home · Open Lab · Lot RGX-26-TESAMORELIN-654
RGX-26-TESAMORELIN-654Superseded
Tesamorelin · 10 MG · Restorative Research · COA NS-2026-05168

Release test results

99.684%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.07 mg
Related impurities (total)0.316%
Endotoxin<1.0 EU/mg
HPLC retention time6.7 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundTesamorelin
Presentation10 MG
Lot numberRGX-26-TESAMORELIN-654
COA numberNS-2026-05168
Test date07 Jan 2026
Release date10 Jan 2026
Independent labNordicstar Labs
StatusSuperseded

Tesamorelin — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-TESAMORELIN-104610 MGJul 16, 202699.753%Current
RGX-26-TESAMORELIN-104720 MGJul 15, 202699.584%Current
RGX-26-TESAMORELIN-75410 MGApr 14, 202699.736%Superseded
RGX-26-TESAMORELIN-75320 MGApr 7, 202699.646%Superseded
RGX-26-TESAMORELIN-654 this lot10 MGJan 7, 202699.684%Superseded
RGX-25-TESAMORELIN-65320 MGDec 28, 202599.667%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →